Cambridge, Massachusetts (MA) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
EPIX Pharmaceuticals Inc
71 Rogers St.
Cambridge MA 02142
(617) 250-6000
Abcam
1 Kendall Square # B2304
Cambridge MA 02139
(617) 577-4200
Genzyme Corp
500 Kendall St.
Cambridge MA 02142
(617) 252-7500
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Genzyme Corporation
500 Kendall St.
Cambridge MA 02142
(617) 252-7500
Genzyme Corporation
55 Cambridge Parkway # 19
Cambridge MA 02142
(508) 271-2919
Akrivis Technologies LLC
1 Broadway Floor 14
Cambridge MA 02142
(617) 233-4097
Cellay Inc
100 Inman St # 201
Cambridge MA 02139
(617) 995-1300
Daktari Diagnostics Inc
85 Bolton St.
Cambridge MA 02140
(617) 336-3299
Jose R Armenteros
897 Main St Apartment 8
Cambridge MA 02139
(305) 962-4701
Metamark Genetics Inc
245 1st St.
Cambridge MA 02142
(617) 583-1400
Eutropics Pharmaceuticals Inc
767C Concord Ave.
Cambridge MA 02138
(617) 714-4405

Eutropics Pharmaceuticals was founded on research and technology originating from the Dana Farber Cancer Institute (DFCI) to enable delivery of person
Whereorg has 13 results under In Vitro and In Vivo Diagnostic Substances Companies in Cambridge, MA.

Narrow down the browsing criteria below to see more companies.

Other locations for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020